Literature DB >> 21658024

A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric 'purinome' concept.

Luca Antonioli, Matteo Fornai, Rocchina Colucci, Marco Tuccori, Corrado Blandizzi.   

Abstract

Adenosine is involved in the modulation of enteric neuromuscular functions, operating a fine tuning of smooth muscle contractility, peristaltic reflex and transit. In this issue of the BJP, Zizzo et al. report novel findings on the expression of adenosine receptors in mouse duodenum, extending our knowledge of their involvement in the control of spontaneous and neurogenic intestinal motility. In this study, particular attention was paid to the differential activation of adenosine receptors, as a result of their interplay with regulatory systems, modulating the availability of endogenous adenosine in a compartmentalised manner. This evidence will contribute to the holistic evaluation of the role played by adenosine in the regulation of intestinal motility, in accordance with the novel concept of the enteric 'purinome'. This commentary discusses the role of the 'purinome' in the modulation of enteric neuromuscular activity, pointing out its involvement in the intestinal neuroplasticity associated with bowel dysmotility.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658024      PMCID: PMC3230805          DOI: 10.1111/j.1476-5381.2011.01529.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis.

Authors:  Luca Antonioli; Matteo Fornai; Rocchina Colucci; Oriana Awwad; Narcisa Ghisu; Marco Tuccori; Mario Del Tacca; Corrado Blandizzi
Journal:  Eur J Pharmacol       Date:  2010-10-27       Impact factor: 4.432

Review 2.  Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.

Authors:  Luca Antonioli; Matteo Fornai; Rocchina Colucci; Narcisa Ghisu; Marco Tuccori; Mario Del Tacca; Corrado Blandizzi
Journal:  Pharmacol Ther       Date:  2008-09-14       Impact factor: 12.310

3.  Adenosine negatively regulates duodenal motility in mice: role of A(1) and A(2A) receptors.

Authors:  M G Zizzo; M Mastropaolo; L Lentini; F Mulè; R Serio
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation.

Authors:  L Antonioli; M Fornai; R Colucci; N Ghisu; M Tuccori; O Awwad; A Bin; C Zoppellaro; I Castagliuolo; R M Gaion; M C Giron; C Blandizzi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Evidence that ATP or a related purine is an excitatory neurotransmitter in the longitudinal muscle of mouse distal colon.

Authors:  M G Zizzo; F Mulè; R Serio
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

6.  Inhibitory responses to exogenous adenosine in murine proximal and distal colon.

Authors:  Maria Grazia Zizzo; Flavia Mulè; Rosa Serio
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

Review 7.  Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.

Authors:  Cinzia Volonté; Nadia D'Ambrosi
Journal:  FEBS J       Date:  2008-12-09       Impact factor: 5.542

8.  Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.

Authors:  Joris G De Man; Tom C Seerden; Benedicte Y De Winter; Eric A Van Marck; Arnold G Herman; Paul A Pelckmans
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A(2A) and extrajunctional inhibitory A(1) receptors.

Authors:  Margarida Duarte-Araújo; Carlos Nascimento; M Alexandrina Timóteo; Teresa Magalhães-Cardoso; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

10.  Relative contribution of ecto-ATPase and ecto-ATPDase pathways to the biphasic effect of ATP on acetylcholine release from myenteric motoneurons.

Authors:  M Duarte-Araújo; C Nascimento; M A Timóteo; M T Magalhães-Cardoso; P Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

  10 in total
  5 in total

Review 1.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Authors:  L Antonioli; M Fornai; O Awwad; G Giustarini; C Pellegrini; M Tuccori; V Caputi; M Qesari; I Castagliuolo; P Brun; M C Giron; C Scarpignato; C Blandizzi; R Colucci
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.

Authors:  Luca Antonioli; Maria Cecilia Giron; Rocchina Colucci; Carolina Pellegrini; Deborah Sacco; Valentina Caputi; Genny Orso; Marco Tuccori; Carmelo Scarpignato; Corrado Blandizzi; Matteo Fornai
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

4.  Post-inflammatory Ileitis Induces Non-neuronal Purinergic Signaling Adjustments of Cholinergic Neurotransmission in the Myenteric Plexus.

Authors:  Cátia Vieira; Fátima Ferreirinha; Maria T Magalhães-Cardoso; Isabel Silva; Patrícia Marques; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2017-11-08       Impact factor: 5.810

5.  Inflammatory Bowel Diseases: It's Time for the Adenosine System.

Authors:  Luca Antonioli; Matteo Fornai; Carolina Pellegrini; Lorenzo Bertani; Zoltan H Nemeth; Corrado Blandizzi
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.